FDA Inspection 1210455 - GC Biopharma Corp_Ochang Plant - April 28, 2023

Record Details

This FDA Inspection record concerns GC Biopharma Corp_Ochang Plant, with an inspection on April 28, 2023, issued by the Office of Inspections and Investigations.

Company: GC Biopharma Corp_Ochang Plant
Inspection Date: April 28, 2023
Office: Office of Inspections and Investigations
People: Gregory A. Price
Malgorzata G. Norton (Company Rep)
Roger F. Zabinski (FDA Associated Person)
Xiuju Lu (Investigator)

View Company Profile

ID · 28ac0380-7b39-42ab-b1ac-180df758bbee

Inspection Facts

Inspection number: 1210455
FDA center: Biologics
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore GC Biopharma Corp_Ochang Plant

FDA Inspection

GC Biopharma Corp_Ochang PlantApril 28, 2023

FDA Inspection 1210455 - GC Biopharma Corp_Ochang Plant - April 28, 2023

Record Details

This FDA Inspection record concerns GC Biopharma Corp_Ochang Plant, with an inspection on April 28, 2023, issued by the Office of Inspections and Investigations.